أدوية ومنتجات صحية
Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter
تفاصيل الاستدعاء أدناه منشورة بالإنجليزية كما أصدرتها الحكومة الكندية دون تعديل. لم تنشر الحكومة صوراً لهذا المنتج.
Summary
| Type | Health product recall |
|---|---|
| Product | Dantrium Intravenous (Dantrolene sodium for injection) |
| Issue | Health products - Contamination |
| What to do | Consult your healthcare provider for any health concerns. |
| Distribution | National |
| Brand(s) | Knight Therapeutics Inc. |
| Last updated | 2026-10-19 |
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Knight Therapeutics Inc. |
Dantrium Intravenous (Dantrolene sodium for injection) |
DIN 01997572 |
Powder For Solution |
20 mg/vial |
80681 |
Issue
Presence of particulate matter in affected lots.
What you should do
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Background
Depth of recall: Healthcare establishments
Details
| Original published date | 2026-10-19 |
|---|---|
| Alert / recall type | Health product recall |
| Category | Health products - Drugs |
| Companies | Knight Therapeutics Inc. |
| Published by | Health Canada |
| Audience | General public Healthcare Industry |
| Distribution | National |
| Recall class | Type I |
| Identification number | RA-82808 |
Source: Government of Canada, Recalls and safety alerts – https://recalls-rappels.canada.ca/en/alert-recall/dantrium-intravenous-dantrolene-sodium-injection-presence-particulate-matter